Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
U.S. FDA approves Lilly migraine drug; price same as rivals
NEW YORK (Reuters) - Eli Lilly and Co on Thursday said the U.
Chronic illnesses: UN stands up to stop 41 million avoidable deaths per year
“Heart disease, stroke, cancer, diabetes, chronic Lyme disease, depression” – just some of the illnesses outlined by World Health Organization (WHO) chief Dr.
Ten minutes of exercise a day might improve memory: study
LOS ANGELES, Sept.
An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice
Growth, progression, and drug resistance of pancreatic ductal adenocarcinomas (PDACs) have been associated with increased levels and activity of glycogen synthase kinase 3 beta (GSK3B)...
Janssen hands back rights to imetelstat
Janssen Biotech has decided to terminate a collaboration and license agreement with Geron Corp for experimental cancer drug imetelstat.
Lilly’s snaps up Chugai’s experimental diabetes drug
Lilly has entered into an agreement to develop Chugai’s OWL833, a oral non-peptidic GLP-1 receptor agonist currently in Phase I for type II diabetes.
U.S.-Cuban biotech venture created to bring new cancer therapies to USA
HAVANA (Reuters) - U.
Alexion To Acquire Syntimmune
BOSTON--(BUSINESS WIRE)--Sep.
Takeda’s Alunbrig shows promise as first-line ALK NSCLC therapy
Takeda’s Alunbrig cut the risk of disease progression or death by more than 50% compared to Pfizer’s Xalkori in adults with ALK+ non-small cell lung cancer.
Malaria 'breakthrough': Disease-carrying mosquitoes wiped out in major lab experiment
Scientists in the U.
GSK vaccine success a milestone in TB, but room for improvement
LONDON (Reuters) - An experimental GlaxoSmithKline vaccine could prevent tuberculosis developing in half of those who receive it, making it potentially the first new shot against the global ki...
FDA is considering banning online sales of e-cigarettes: Gottlieb
Washington D.
462
463
464
465
466
467
468
469
470
